Pharmafile
Therapeutic areas in focus
Aaron Bean at Veeva explores the challenges of rare diseases: With up to 30 million people in EU living with rare diseases, Veeva discusses the challenges facing these rare diseases
Pharmafile speaks to Chiesi Group: Chiesi Group tells Pharmafile about the challenges facing rare disease research and their hopes for the future of this area
Patient advocacy organisations can form an effective partnership between clinical trials and patients for more efficient trials
The rare disease treatment market has been rapidly changing and receive deserved recognition
Many advancements have been made within the rare disease field, including gene editing and viral delivery strategies